abstract |
The invention relates to pyridazinone-, pyrazolone- and pyridone-naphteridone substituted compounds useful as cardiotonic agents for the treatment of congestive heart disorders, methods of increasing cardiac contractility using said compounds, as well as than pharmaceutical compositions containing them. |